# Nervgen Pharma Corp.: filings

NGEN · Nasdaq · CIK 1751912 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ngen.md) · [Financials](/companies/ngen/financials.md) · [Filings](/companies/ngen/filings.md) · [Insiders](/companies/ngen/insiders.md)

## Reports and events: 15 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 14, D 7, SUPPL 4, D/A 2, EFFECT 2, F-10 2, F-X 2, S-8 2, 40-F 1, 40-F/A 1, 6-K/A 1, 8-A12B 1, CERT 1, F-10/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 20:30 ET | [6-K](/filings/0001104659-26-111004.md) | Report of a foreign private issuer, period 2026-09-25 | 0001104659-26-111004 |
| 2026-09-24 | 12:27 ET | [6-K](/filings/0001104659-26-110225.md) | Report of a foreign private issuer, period 2026-09-24 | 0001104659-26-110225 |
| 2026-08-13 | 11:31 ET | [6-K](/filings/0001104659-26-095467.md) | Report of a foreign private issuer, period 2026-08-13 | 0001104659-26-095467 |
| 2026-07-02 | 21:23 ET | [6-K](/filings/0001104659-26-080432.md) | Report of a foreign private issuer, period 2026-07-02 | 0001104659-26-080432 |
| 2026-06-01 | 21:29 ET | [6-K](/filings/0001104659-26-069028.md) | Report of a foreign private issuer, period 2026-06-01 | 0001104659-26-069028 |
| 2026-05-26 | 20:35 ET | [6-K](/filings/0001104659-26-066307.md) | Report of a foreign private issuer, period 2026-05-26 | 0001104659-26-066307 |
| 2026-05-22 | 21:24 ET | [6-K](/filings/0001104659-26-065821.md) | Report of a foreign private issuer, period 2026-05-22 | 0001104659-26-065821 |
| 2026-05-18 | 20:19 ET | [6-K](/filings/0001104659-26-063212.md) | Report of a foreign private issuer, period 2026-05-18 | 0001104659-26-063212 |
| 2026-05-15 | 20:28 ET | [6-K](/filings/0001104659-26-062618.md) | Report of a foreign private issuer, period 2026-05-15 | 0001104659-26-062618 |
| 2026-04-27 | 21:05 ET | [6-K](/filings/0001104659-26-049508.md) | Report of a foreign private issuer, period 2026-04-27 | 0001104659-26-049508 |
| 2026-03-31 | 11:30 ET | [40-F](/filings/0001104659-26-037357.md) | Annual report of a Canadian issuer, period 2025-12-31 | 0001104659-26-037357 |
| 2026-03-13 | 21:04 ET | [6-K](/filings/0001104659-26-027740.md) | Report of a foreign private issuer, period 2026-03-13 | 0001104659-26-027740 |
| 2026-02-13 | 21:05 ET | [6-K](/filings/0001104659-26-015192.md) | Report of a foreign private issuer, period 2026-02-13 | 0001104659-26-015192 |
| 2026-02-10 | 21:05 ET | [6-K](/filings/0001104659-26-012610.md) | Report of a foreign private issuer, period 2026-02-10 | 0001104659-26-012610 |
| 2026-01-08 | 21:09 ET | [6-K](/filings/0001104659-26-002130.md) | Report of a foreign private issuer, period 2026-01-08 | 0001104659-26-002130 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.